Pathological Mechanism Study of Aerobic Exercise Regulating Cold Stress-induced Hypertension Via the Thermosensitive Target-mediated Sympathetic Nerve Pathway
1 other identifier
observational
200
1 country
1
Brief Summary
This study focuses on the specificity of thermosensitive targets in populations with hypertension in cold regions, identifies core targets through transcriptome sequencing and clinical validation, and clarifies the regulatory mechanism of moderate-intensity aerobic exercise through a prospective cohort study, providing scientific basis for precise prevention and treatment of hypertension in cold regions and personalized exercise intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2025
CompletedFirst Submitted
Initial submission to the registry
June 13, 2026
CompletedFirst Posted
Study publicly available on registry
June 24, 2026
CompletedJune 24, 2026
June 1, 2026
1.2 years
June 13, 2026
June 18, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
blood pressure (BP)
Systolic blood pressure, unit: mmHg Diastolic blood pressure, unit: mmHg Mean arterial pressure, unit: mmHg
December 28, 2025
heart rate variability (HRV)
Low Frequency,Unit: nu High Frequency ,Unit: nu Low Frequency / High Frequency ratio Root Mean Square of Successive Differences,Unit: ms Percentage of successive NN intervals differing by more than 50 ms,Unit: % Standard Deviation of all Normal-to-Normal RR intervals,Unit: ms
28 December 2025
markers of the sympathetic nervous system (SNS)
Epinephrine, unit: ng/L Norepinephrine, unit: ng/L
December 28, 2025
mRNA expression of genes
Unit: relative expression level
December 28, 2025
Interventions
Patients with essential hypertension in cold regions who met the inclusion criteria were prospectively recruited and divided into an exercise exposure group and a non-exercise control group based on their willingness to accept and adhere to the exercise protocol developed for this study, with a follow-up period of 16 weeks. At baseline and the end of follow-up, we measured the expression of core thermosensitive targets, blood pressure (BP), heart rate variability (HRV), as well as the levels of sympathetic neurotransmitters and indicators of the renin-angiotensin-aldosterone system (RAAS), and compared the changes in these indicators between the two groups.
Eligibility Criteria
Hypertensive population
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wang Jingfenglead
Study Sites (1)
Harbin Sport University
Harbin, Heilongjiang, 150008, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 16 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Ph.D.
Study Record Dates
First Submitted
June 13, 2026
First Posted
June 24, 2026
Study Start
October 4, 2024
Primary Completion
December 28, 2025
Study Completion
December 28, 2025
Last Updated
June 24, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share